Literature DB >> 17915627

Long-term mizoribine intermittent pulse therapy, but not azathioprine therapy, attenuated histologic progression in a patient with severe lupus nephritis.

H Tanaka, K Tsugawa, E Oki, K Suzuki, S Waga, E Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17915627     DOI： 10.5414/cnp68198

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


× No keyword cloud information.
  2 in total

Review 1.  Mizoribine in the treatment of pediatric-onset glomerular disease.

Authors:  Hiroshi Tanaka; Kazushi Tsuruga; Taddatsu Imaizumi
Journal:  World J Pediatr       Date:  2015-03-09       Impact factor: 2.764

2.  Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis.

Authors:  Hiroshi Tanaka; Eishin Oki; Kazushi Tsuruga; Tomomi Aizawa-Yashiro; Yuya Ito; Norihiro Sato; Yukihiko Kawasaki; Junzo Suzuki
Journal:  Clin Rheumatol       Date:  2010-05-19       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.